Wellgistics Health, Inc.
WGRX
$4.51
-$0.05-1.10%
| Weiss Ratings | WGRX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | WGRX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | WGRX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | WGRX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 7.64% | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | 18.37% | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -19.86% | |||
| 52-Week Low % Change | 96.55% | |||
| Price | WGRX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $5.69 | |||
| 52-Week Low Price | $2.32 | |||
| 52-Week Low Price (Date) | Feb 25, 2025 | |||
| 52-Week High Price (Date) | Mar 21, 2025 | |||
| Valuation | WGRX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 236.87M | |||
| Enterprise Value | 260.84M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.27 | |||
| Earnings Per Share Growth | 502.93% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 12.27 | |||
| Price/Book (Q) | 16.14 | |||
| Enterprise Value/Revenue (TTM) | 14.39 | |||
| Price | $4.51 | |||
| Enterprise Value/EBITDA (TTM) | -54.57 | |||
| Enterprise Value/EBIT | -42.45 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | WGRX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 48.78M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | WGRX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | (844) 203-6092 | |||
| Address | 3000 Bayport Drive Tampa, FL 33607 | |||
| Website | www.wellgisticshealth.com | |||
| Country | United States | |||
| Year Founded | 2022 | |||
| Profitability | WGRX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -33.89% | |||
| Profit Margin | -37.81% | |||
| Management Effectiveness | WGRX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -13.32% | |||
| Return on Equity | -- | |||
| Income Statement | WGRX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 18.13M | |||
| Total Revenue (TTM) | 18.13M | |||
| Revenue Per Share | $0.37 | |||
| Gross Profit (TTM) | 1.77M | |||
| EBITDA (TTM) | -4.78M | |||
| EBIT (TTM) | -6.15M | |||
| Net Income (TTM) | -6.86M | |||
| Net Income Avl. to Common (TTM) | -6.86M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -302.51% | |||
| EPS Diluted (TTM) | -0.27 | |||
| EPS Diluted Growth (Q YOY) | -656.43% | |||
| Balance Sheet | WGRX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.03M | |||
| Cash Per Share (Q) | $0.02 | |||
| Total Current Assets (Q) | 15.17M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 6.73M | |||
| Current Ratio (Q) | 0.399 | |||
| Book Value Per Share (Q) | $0.28 | |||
| Total Assets (Q) | 57.33M | |||
| Total Current Liabilities (Q) | 38.05M | |||
| Total Debt (Q) | 25.00M | |||
| Total Liabilities (Q) | 50.60M | |||
| Total Common Equity (Q) | 6.73M | |||
| Cash Flow | WGRX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 469.10K | |||
| Cash from Financing (TTM) | 1.78M | |||
| Net Change in Cash (TTM) | 1.03M | |||
| Levered Free Cash Flow (TTM) | 7.20M | |||
| Cash from Operations (TTM) | -1.23M | |||
